Cite
Murillo-Cuesta S, Celaya AM, Cervantes B, et al. Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss. Clin Transl Med. 2021;11(4):e363doi: 10.1002/ctm2.363.
Murillo-Cuesta, S., Celaya, A. M., Cervantes, B., Bermúdez-Muñoz, J. M., Rodríguez-de la Rosa, L., Contreras, J., Sánchez-Pérez, I., & Varela-Nieto, I. (2021). Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss. Clinical and translational medicine, 11(4), e363. https://doi.org/10.1002/ctm2.363
Murillo-Cuesta, Silvia, et al. "Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss." Clinical and translational medicine vol. 11,4 (2021): e363. doi: https://doi.org/10.1002/ctm2.363
Murillo-Cuesta S, Celaya AM, Cervantes B, Bermúdez-Muñoz JM, Rodríguez-de la Rosa L, Contreras J, Sánchez-Pérez I, Varela-Nieto I. Therapeutic efficiency of the APAF-1 antagonist LPT99 in a rat model of cisplatin-induced hearing loss. Clin Transl Med. 2021 Apr;11(4):e363. doi: 10.1002/ctm2.363. PMID: 33931965; PMCID: PMC8021538.
Copy
Download .nbib